These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34574648)

  • 1. Workers with Cardiac AIMD Exposed to EMF: Methods and Case Studies for Risk Analysis in the Framework of the European Regulations.
    Mattei E; Censi F; Calcagnini G; Falsaperla R
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the safety of users of active implantable medical devices (AIMD) in the working environment in terms of exposure to electromagnetic fields - Practical approach to the requirements of European Directive 2013/35/EU.
    Zradziński P; Karpowicz J; Gryz K; Leszko W
    Int J Occup Med Environ Health; 2018 Dec; 31(6):795-808. PubMed ID: 30520435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of the risk due to exposure to EMF with particular reference to the protection of sensitive subjects].
    Falsaperla R; Mattei E; Censi F; Bogi A; Pinto I; Calcagnini G
    G Ital Med Lav Ergon; 2019 Dec; 41(4):280-284. PubMed ID: 32126594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pacemakers, Implantable Defibrillators, and 5G Technology: What We Need to Know.
    Mattei E; Vivarelli C; Franci D; Pavoncello S; Aureli T; Calcagnini G; Censi F
    Health Phys; 2023 Sep; 125(3):202-206. PubMed ID: 37195187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter defibrillator and 50-Hz electric and magnetic fields exposure in the workplace.
    Souques M; Magne I; Lambrozo J
    Int Arch Occup Environ Health; 2011 Jan; 84(1):1-6. PubMed ID: 21069535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electromagnetic interference : Pacemakers, cardiac resynchronization therapy devices, implantable cardioverter-defibrillator].
    Nowak B; Przibille O; Napp A
    Herzschrittmacherther Elektrophysiol; 2022 Sep; 33(3):297-304. PubMed ID: 35781834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electromagnetic interference with cardiac pacemakers and implantable cardioverter-defibrillators from low-frequency electromagnetic fields in vivo.
    Tiikkaja M; Aro AL; Alanko T; Lindholm H; Sistonen H; Hartikainen JE; Toivonen L; Juutilainen J; Hietanen M
    Europace; 2013 Mar; 15(3):388-94. PubMed ID: 23125355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recommendations for protection against electromagnetic interference risk caused by pacemakers and implantable defibrillators in hospitals].
    Santomauro M; Da Prato D; Ottaviano L; Borrelli A; Chiariello M
    Ital Heart J Suppl; 2002 Apr; 3(4):440-5. PubMed ID: 12025389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are patients with cardiac implants protected against electromagnetic interference in daily life and occupational environment?
    Napp A; Stunder D; Maytin M; Kraus T; Marx N; Driessen S
    Eur Heart J; 2015 Jul; 36(28):1798-804. PubMed ID: 25908772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electromagnetic immunity of medical devices: the European regulatory framework.
    Calcagnini G; Censi F; Bartolini P
    Ann Ist Super Sanita; 2007; 43(3):268-76. PubMed ID: 17938458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The influence of non-ionizing electromagnetic fields on implantable cardiac medical devices].
    Souques M
    Presse Med; 2004 Dec; 33(22):1611-5. PubMed ID: 15685115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The development of the new guidelines of the Italian association of medical radioprotection (AIRM) for the protection of the workers exposed to EMF related risks: new approaches and criteria].
    Gobba F; Modonese A
    G Ital Med Lav Ergon; 2020 Dec; 42(4):304-309. PubMed ID: 33600659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro tests reveal sample radiofrequency identification readers inducing clinically significant electromagnetic interference to implantable pacemakers and implantable cardioverter-defibrillators.
    Seidman SJ; Brockman R; Lewis BM; Guag J; Shein MJ; Clement WJ; Kippola J; Digby D; Barber C; Huntwork D
    Heart Rhythm; 2010 Jan; 7(1):99-107. PubMed ID: 20129290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An assessment of hazards caused by electromagnetic interaction on humans present near short-wave physiotherapeutic devices of various types including hazards for users of electronic active implantable medical devices (AIMD).
    Karpowicz J; Gryz K
    Biomed Res Int; 2013; 2013():150143. PubMed ID: 24089662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vitro evaluation of electromagnetic interference between implantable cardiac devices and ophthalmic laser systems.
    Sher NA; Golben MP; Kresge K; Selznick L; Adabag S
    Europace; 2011 Apr; 13(4):583-8. PubMed ID: 21252191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of electromagnetic interference induced by dental equipment on cardiac implantable electrical devices.
    Miranda-Rius J; Lahor-Soler E; Brunet-Llobet L; Sabaté de la Cruz X
    Eur J Oral Sci; 2016 Dec; 124(6):559-565. PubMed ID: 27748971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electromagnetic interference in cardiac electronic implants caused by novel electrical appliances emitting electromagnetic fields in the intermediate frequency range: a systematic review.
    Driessen S; Napp A; Schmiedchen K; Kraus T; Stunder D
    Europace; 2019 Feb; 21(2):219-229. PubMed ID: 29992289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of electromagnetic interference on implanted cardiac devices and their management.
    Yerra L; Reddy PC
    Cardiol Rev; 2007; 15(6):304-9. PubMed ID: 18090066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occupational Exposure to Electromagnetic Fields and Health Surveillance According to the European Directive 2013/35/EU.
    Modenese A; Gobba F
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33579004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of pacemakers and implantable cardioverter defibrillators in urological practice.
    Ubee SS; Kasi VS; Bello D; Manikandan R
    J Urol; 2011 Oct; 186(4):1198-205. PubMed ID: 21849189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.